DermTech, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
DermTech, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2018 to Q4 2023.
  • DermTech, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $102M, a 27.7% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $102M +$22.2M +27.7% Dec 31, 2023 10-K 2024-02-29
Q4 2022 $80.2M +$27.8M +53% Dec 31, 2022 10-K 2024-02-29
Q4 2021 $52.4M +$21.3M +68.3% Dec 31, 2021 10-K 2023-03-02
Q4 2020 $31.1M +$9.06M +41% Dec 31, 2020 10-K 2022-03-10
Q4 2019 $22.1M +$4.56M +26% Dec 31, 2019 10-K 2022-03-10
Q4 2018 $17.5M Dec 31, 2018 10-K 2020-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.